In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Teva, Alpharma sign deal to sell gabapentin

Executive Summary

Generics companies Teva Pharmaceutical Industries and Alpharma will work together on the launch and marketing of capsule and tablet formulations of gabapentin, the generic version of Pfizer's anticonvulsant Neurontin.
Deal Industry
  • Pharmaceuticals
    • Generic Drugs
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing-Licensing

Related Companies

Advertisement
UsernamePublicRestriction

Register